Celldex Therapeutics shares owned by Scarborough Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Scarborough Advisors
from 13F filings
Historical chart of Scarborough Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Scarborough Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Scarborough Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $121 | 6 | 20.33 |
| 2024-06-30 | $222 | 6 | 37.00 |
| 2024-03-31 | $252 | 6 | 42.00 |
| 2023-12-31 | $238 | 6 | 39.67 |